Leukemia is treatable, and many people go into remission or recover completely
Yes, leukemia is treatable. The outcome depends on the type of leukemia, your age, how advanced it is when found, and how your body responds to treatment. Some people achieve complete remission—meaning cancer cells are no longer detectable—and stay cancer-free for years or decades. Others manage leukemia as a chronic condition with ongoing treatment. A small number of people do not respond well to standard treatments, but new options continue to emerge.
The word "treatable" does not mean the same thing for every person or every type. Acute lymphoblastic leukemia (ALL) in children has remission rates above 85 percent. Chronic myeloid leukemia (CML) in adults often becomes manageable with targeted drugs that can extend life for many years. Acute myeloid leukemia (AML) in older adults has lower remission rates but still responds to treatment in a significant portion of cases. Your doctor can give you a clearer picture once they know your specific diagnosis.
Key Takeaways
- Remission rates vary widely by leukemia type and age, ranging from over 85 percent for childhood ALL to lower rates for some forms of AML.
- Standard treatments include chemotherapy, targeted drugs, immunotherapy, and stem cell transplant, often used in combination.
- Complete remission means cancer cells are undetectable, but some people need ongoing maintenance treatment to stay in remission.
- Side effects are common during treatment but often manageable with supportive care, and many fade after treatment ends.
- Clinical trials offer access to newer treatments when standard options have not worked or as a first-line choice for some diagnoses.
How chemotherapy and targeted drugs work against leukemia
Chemotherapy uses drugs that kill fast-growing cells, including cancer cells. Because leukemia cells divide rapidly, chemotherapy can be very effective, but it also damages some healthy cells, which causes side effects. Chemotherapy is often given in cycles—a period of treatment followed by a recovery period—to let your body heal between doses.
Targeted drugs work differently. They attack specific features of leukemia cells that healthy cells do not have. For example, imatinib (Gleevec) targets a protein found in chronic myeloid leukemia cells. Because targeted drugs are more precise, they often cause fewer side effects than chemotherapy. Many people with CML take a targeted drug as their main treatment for years.
Your doctor may use chemotherapy alone, a targeted drug alone, or both together, depending on your diagnosis. The goal in the first phase—called induction therapy—is to kill enough leukemia cells that none are detectable in your blood or bone marrow. Once remission is reached, you may receive additional treatment, called consolidation or maintenance therapy, to prevent the cancer from returning.
Immunotherapy and CAR-T cell therapy for harder-to-treat cases
Immunotherapy drugs help your own immune system recognize and destroy leukemia cells. Monoclonal antibodies like rituximab attach to leukemia cells and mark them for destruction. Other immunotherapy drugs remove the "brakes" that leukemia cells use to hide from your immune system, allowing your body's defenses to attack them.
CAR-T cell therapy is a newer approach in which doctors remove some of your immune cells, reprogram them in the laboratory to recognize leukemia cells, and infuse them back into your body. This treatment has shown dramatic results in certain types of leukemia, particularly in people who did not respond to chemotherapy. It is more complex and carries different risks than chemotherapy, but for some patients it offers a path to remission when other treatments have failed.
These approaches are often used after chemotherapy or when chemotherapy alone has not worked. They represent a shift toward treatments that work with your body's natural defenses rather than simply poisoning cancer cells.
Stem cell transplant: when and why it is used
A stem cell transplant (also called a bone marrow transplant) replaces your leukemia-damaged bone marrow with healthy stem cells from a donor or from your own cells collected and stored earlier. The transplant itself is not the treatment—it is the rescue after high-dose chemotherapy or radiation that would otherwise destroy your bone marrow.
Transplant is typically considered when leukemia is high-risk, when it returns after initial treatment, or when a person is young and healthy enough to tolerate the procedure. Finding a matched donor is a major hurdle; a sibling is often the best match, but unrelated donors can be found through registries. The transplant process takes weeks in the hospital and months of recovery at home, and it carries real risks, including infection and a condition called graft-versus-host disease where the new immune cells attack your body.
Despite these challenges, a successful transplant can offer the best chance of long-term remission or cure for certain patients. Your doctor will weigh the risks and benefits based on your age, overall health, leukemia type, and how the cancer has responded to earlier treatment.
What remission means and what happens after
Complete remission means leukemia cells are no longer detectable in your blood or bone marrow using standard tests. It does not necessarily mean the cancer is gone forever—a small number of leukemia cells may remain undetected—but it means the disease is under control and you can return to many normal activities.
After remission is achieved, you enter a monitoring phase. You will have regular blood tests and bone marrow biopsies (usually less frequent over time) to watch for any sign of the cancer returning. Some people need maintenance therapy—lower doses of chemotherapy or targeted drugs taken over months or years—to keep leukemia in remission. Others stop treatment entirely and are monitored closely. The plan depends on your leukemia type and how it behaves.
Remission can last months, years, or a lifetime. Some leukemias, like CML, often stay in remission as long as you take your targeted drug. Others, like AML, have a higher risk of returning, which is why longer-term treatment or transplant may be recommended. Your doctor will discuss the likelihood of relapse and the plan to catch it early if it happens.
Managing side effects during and after treatment
Chemotherapy and other leukemia treatments cause side effects because they affect healthy cells too. Common ones include nausea, fatigue, hair loss, low blood counts (which raise infection risk), and mouth sores. These are real and can be difficult, but they are usually temporary and manageable.
Your medical team will offer medications and strategies to reduce side effects: anti-nausea drugs, antibiotics or antifungals to prevent infection when your white blood cell count is low, nutritional support, and pain management. Many side effects fade within weeks or months after treatment ends. Some, like nerve damage or heart effects, can be longer-lasting, which is why your doctor monitors you after treatment is complete.
Fertility and pregnancy are concerns for younger people. Some leukemia treatments can affect your ability to have children. If this matters to you, discuss it with your doctor before treatment starts; options like egg or sperm banking may be possible.
Clinical trials and newer treatment options
If standard treatments have not worked or if you want access to newer approaches, clinical trials may be an option. Trials test new drug combinations, new targeted drugs, improved immunotherapy, and other innovations. Some trials are for people newly diagnosed; others are for people whose leukemia has returned or resisted treatment.
You can search for trials at ClinicalTrials.gov, which lists trials by location and leukemia type. Your oncologist may also know of trials at your hospital or nearby cancer centers. Trials do not cost you money, but they do require time and travel, and there is no may provide the new treatment will work better than standard care. Your doctor can help you weigh whether a trial makes sense for your situation.
Frequently Asked Questions
What is the difference between remission and cure?
Remission means the cancer is no longer detectable. Cure means it will never return. For leukemia, doctors usually use the word remission because some leukemias can return years later, even after long periods without symptoms. Some people do achieve what amounts to a cure—they live out their normal lifespan with no sign of leukemia—but doctors are cautious about using that word until many years have passed.
Can leukemia come back after remission?
Yes, some leukemias relapse. The risk varies by type and how well the initial treatment worked. If leukemia returns, it does not mean the first treatment failed—it means the cancer adapted. Second-line treatments, clinical trials, or stem cell transplant may be options. Relapse is serious but not the end of treatment possibilities.
How long does leukemia treatment take?
Induction therapy (the first phase to reach remission) usually takes weeks to a few months. Consolidation or maintenance therapy can last months to years depending on the type. Some people with chronic leukemias take targeted drugs indefinitely. Your doctor will outline the expected timeline for your specific diagnosis and treatment plan.
Do all leukemia patients need a stem cell transplant?
No. Many people achieve remission and long-term survival with chemotherapy, targeted drugs, or immunotherapy alone. Transplant is reserved for high-risk cases, relapses, or situations where other treatments have not worked. Your age, overall health, and how your leukemia responds to initial treatment determine whether transplant is recommended.
What happens if I do not respond to the first treatment?
If leukemia does not go into remission or returns quickly after treatment, your doctor will discuss second-line options. These may include a different chemotherapy regimen, a targeted drug, immunotherapy, CAR-T cell therapy, or a clinical trial. Leukemia that resists initial treatment is harder to manage, but newer drugs and approaches continue to expand the options available.